Back to BlackRock, Inc. BlackRock, Inc.

JAZZJAZZ
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in JAZZ PHARMACEUTICALS PLC

Yes. BlackRock holds 5,968,603 shares of JAZZ (Jazz Pharmaceuticals), worth $1.4B, as of its Q2 2026 13F filing. It increased the position by 376,903 shares (+6.7%) from Q1 2026. BlackRock has held JAZZ in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$1.4B

Current Shares

6M

Total Value Change

+$784M

Total Shares Change

+95,968

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6M
+6.7%
$1.4B0.0%$240.97
34
2026-Q1
Increased
5.6M
+2.6%
$1.1B0.0%$189.05
33
2025-Q4
Decreased
5.5M
-1.9%
$926.7M0.0%$170.00
0
2025-Q3
Decreased
5.6M
-4.2%
$732.7M0.0%$131.80
0
2025-Q2
Increased
5.8M
+0.6%
$615.5M0.0%$106.12
32
2025-Q1
Decreased
5.8M
-1.5%
$715.8M0.0%$124.15
0
2024-Q4
Decreased
5.9M
-0.4%
$720.6M0.0%$123.15
0
2024-Q3
First report
5.9M
-
$654.3M0.0%$111.41
0

Other major holders of JAZZ: FMR LLC, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used